Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Immunotherapy Drugs Slow Skin Cancer That Has Spread to the Brain
New York Times, NY
Thu, 08/23/18 - 11:19 am
melanoma
Opdivo
clinical trials
Bristol-Myers Squibb
Bristol-Myers will sell Opdivo in China at half of US cost, setting precedent for checkpoint wave — report
Endpoints
Wed, 08/22/18 - 09:38 am
Bristol-Myers Squibb
China
Opdivo
drug pricing
Bristol Nabs Immunotherapy’s First FDA Nod for Small Cell Lung Cancer
Xconomy
Fri, 08/17/18 - 11:45 am
FDA
Opdivo
Bristol-Myers Squibb
small cell lung cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
CP Wire
Wed, 08/8/18 - 09:35 am
Clovis Oncology
clinical trials
Bristol-Myers Squibb
Opdivo
ovarian cancer
Clovis Starts Ph III Trial with Combination of Rubraca and Opdivo in Advanced Ovarian Cancer
Wed, 08/8/18 - 09:01 am
Clovis Oncology
Rubraca
Opdivo
ovarian cancer
After an epic battle of blockbusters, Merck leapfrogs Bristol-Myers to take the lead on PD-1/L1 market
Endpoints
Sat, 07/28/18 - 01:02 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
anti-PD-L1
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
CP Wire
Thu, 07/19/18 - 10:05 am
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
Yervoy
GRANITE-001
cancer
Bristol-Myers Squibb and Gritstone Oncology Announce Collaboration to Evaluate Novel Immunotherapy Approach in Advanced Solid Tumors
Thu, 07/19/18 - 09:46 am
Bristol-Myers Squibb
Gritstone Oncology
Opdivo
Opdivo Gains New Approval in Combination with Yervoy
CP Wire
Wed, 07/11/18 - 11:32 am
Opdivo
Yervoy
Bristol-Myers Squibb
metastatic colorectal cancer
Bristol-Myers clears another hurdle in Merck lung cancer showdown — but big challenges remain
Endpoints
Fri, 06/22/18 - 09:57 am
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Bristol-Myers wins the frenzied race to a first approval for a PD-1/L1 checkpoint in China as regulators hustle up a quick OK
Endpoints
Fri, 06/15/18 - 09:37 am
Bristol-Myers Squibb
Opdivo
China
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
Fierce Pharma
Fri, 06/8/18 - 09:48 am
Humira
AbbVie
Keytruda
Merck
Revlimid
Celgene
Opdivo
Bristol-Myers Squibb
ASCO18: 3 unanswered questions from oncology's largest conference
Biopharma Dive
Thu, 06/7/18 - 09:35 am
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
immunotherapy combinations
non-small cell lung cancer
ASCO: Bristol-Myers racks up Opdivo combo data to sell its new biomarker, but will doctors buy it?
Fierce Pharma
Mon, 06/4/18 - 10:24 pm
Bristol-Myers Squibb
biomarkers
ASCO 2018
Opdivo
Ahead of ASCO, BMS' Opdivo leads Merck's Keytruda in U.S. sales—but not for long, analyst predicts
Fierce Pharma
Fri, 06/1/18 - 11:49 am
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
5 Best-Selling Orphan Drugs in the U.S.
Motley Fool
Wed, 05/30/18 - 09:13 pm
orphan drugs
Celgene
Revlimid
Roche
Rituxan
Teva Pharmaceutical
Copaxone
Opdivo
Bristol-Myers Squibb
Merck
Keytruda
BMY Is Rapidly Advancing Its First-Line NSCLC Research Program
Market Realist
Mon, 05/28/18 - 01:26 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Yervoy
5 takeaways from the first look at cancer's biggest conference
Biopharma Dive
Thu, 05/17/18 - 10:44 pm
ASCO
Regeneron
cemiplimab
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
Nektar
NKTR-214
Loxo Oncology
LOXO-292
Jounce Therapeutics
JTX-2011
EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
CP Wire
Thu, 05/3/18 - 11:16 am
Bristol-Myers Squibb
Opdivo
Yervoy
metastatic non-small cell lung cancer
EMA
Europe
EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
Thu, 05/3/18 - 09:24 am
Bristol-Myers Squibb
non-small cell lung cancer
Opdivo
Yervoy
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »